| Text 
- Klinische Studien
- Produkte in der Entwicklung
- Novartis-Stiftung für therapeutische Forschung
- Phasen der Arzneimittel- entwicklung
- Arzneimittelforschung und Tiere bei Novartis
Publikationen aus geförderten Projekten
Förderthematik der Ausschreibung des Jahres 2006:
„(Pro)-Renin und Reninrezeptor – pathophysiologische Bedeutung jenseits der Angiotensin II-Synthese“
-
Fischer R et al. (Müller D N): Dietary n-3 Polyunsaturated Fatty Acids and Direct Renin Inhibition Improve Electrical Remodeling in a Model of High Human Renin Hypertension: Hypertension online Dez 24 (2007)
-
Müller D N et al. : (Pro)Renin Receptor Peptide Inhibitor "Handle-Region" Peptide Does Not Affect Hypertensive Nephrosclerosis in Goldblatt Rats: Hypertension online Jan 22 (2008)
-
Feldt S et al. (Müller D N): Prorenin and Renin-Induced Extracellular Signal Regulated Kinase 1/2 Activation in Monocytes Is Not Blocked by Aliskiren or the Handle-Region Peptide: Hypertension online Jan 22 (2008)
-
Feldt S et al. (Müller D N ): The Putative (Pro)renin Receptor Blocker HRP Fails to Prevent (Pro)renin Signaling: J Am Soc Nephrol Jan 30 (2008)
-
Zöllinger A et al. (Stühmer T, Bargou R C): Combined functional and molecular analysis of tumor cell signaling defines two distinct myeloma subgroups: Akt-dependent and Akt-independent multiple myeloma: Blood online Jul 17 (2008)
Förderthematik der Ausschreibung des Jahres 2005:
„Transkriptionale Regulation und Inflammation bei Arteriosklerose und Adipositas“
-
Thum T et al. (Bauersachs J): Bone marrow molecular alterations after myocardial infarction: Impact on endothelial progenitor cells: Cardiovascular Research 70 (2006) 50-60
-
Thum T et al. (Bauersachs J): Endothelial Nitric Oxide Synthase Uncoupling Impairs Endothelial Progenitor Cell Mobilization and Function in Diabetes: Diabetes 56 (2007) 666-674
-
Thum T et al. (Bauersachs J): Differential Effects of Organic Nitrates on Endothelial Progenitor Cells Are Determined by Oxidative Stress: Arterioscler Thromb Vasc Biol. (2007) 27, 748-754
-
Thum T et al. (Bauersachs J): Age-Dependent Impairment of Endothelial Progenitor Cells Is Corrected by Growth Hormone Mediated Increase of Insulin-Like Growth Factor-1: Circulation Research (2007) 100, 434-443
-
Daub K et al. (Langer H, May A E, Gawaz M): Platelets induce differentiation of human CD34+ progenitor cells into foam cells and endothelial cells: The FASEB Journal (2006) 20, E1-E10
-
Langer H F et al. (May A E, Gawaz M): Platelets Recruit Human Dendritic Cells Via Mac-1/ JAM-C Interaction and Modulate Dendritic Cell Function In Vitro: Arterioscler Thromb Vasc Biol. (2007) 27, 1-9
-
Lindemann S et al. (Gawaz M): Molecular pathways used by platelets to initiate and accelerate atherogenesis: Current Opinion in Lipidology (2007) 18, 566-573
-
Schmidt R et al. (May A E, Gawaz M): Extracellular Matrix Metalloproteinase Inducer (CD147) Is a Novel Receptor on Platelets, Activates Platelets, and Augments Nuclear Factor kB-Dependent Inflammation in Monocytes: Circ Res. (2008) 102, 1-8
-
Stellos K et al. (Langer H, May A E, Gawaz M): Platelet-Derived Stromal Cell Derived Factor-1 Regulates Adhesion and Promotes Differentiation of Human CD34+Cells to Endothelial Progenitor Cells: Circulation (2008) 117, 206-215
-
Schönberger T et al. (Gawaz M): The immunoadhesin glycoprotein VI-Fc regulates arterial remodeling after mechanical injury in ApoE-/- mice: Cardiovascular Research (2008) accepted
Förderthematik der Ausschreibung des Jahres 2004:
„Transkriptionale Regulation und Inflammation bei Arteriosklerose und Adipositas“
-
Schroeter M R et al. (Konstantinides S, Schäfer K): Leptin Enhances the Recruitment of Endothelial Progenitor Cells Into Neointimal Lesions After Vascular Injury by Promoting Integrin-Mediated Adhesion: Circ. Res. online Jul 24 (2008)
Förderthematik der Ausschreibung des Jahres 2003:
„Kardiale Regeneration mittels Stamm- / Progenitorzellen“
-
Eschenhagen T, Zimmermann WH: Engineering myocardial tissue: Circ Res 97:1220-1231 (2005)
-
Naito H et al. (Eschenhagen T, Zimmermann WH): Optimizing engineered heart tissue for therapeutic applications as surrogate heart muscle: Circulation 114:I72-78 (2006)
-
Zimmermann WH et al. (Eschenhagen T): Heart muscle engineering: an update on cardiac muscle replacement therapy: Cardiovasc Res 71:419-429 (2006)
-
Zimmermann WH, Eschenhagen T: Embryonic stem cells for cardiac muscle engineering: Trends Cardiovasc Med 17:134-140 (2007)
-
Yildirim Y et al. (Eschenhagen T, Zimmermann WH): Development of a Biological Ventricular Assist Device (BioVAD): Preliminary Data from a Small Animal Model: Circulation 116:I16-23 (2007)
-
Zimmermann WH et al. (Eschenhagen T): Cardiac tissue engineering: a clinical perspective: Future Cardiol 3:435-445 (2007)
-
M. Hofmann et al. (K. C. Wollert, G.P. Meyer, H. Drexler): Monitoring of Bone Marrow Cell Homing into the Infarcted Human Myocardium: Circulation 2005;111:2198-2202
-
Keiper T et al. (Iserman B, Chavakis T): The role of junctional adhesion molecule-C (JAM-C) in oxidized LDL-mediated leukocyte recruitment: FASEB J. 2005 Sep 29
-
T. Chavakis et al.: Angiostatin is a Novel Anti-inflammatory Factor by Inhibiting Leukocyte Recruitment: Blood; 105:1036-43, 2005
-
Keiper T, Chavakis T et al.: The role of junctional adhesion molecules in cell-cell interactions: Histol. Histopathol. 20:197-203, 2005
-
Sotirios N et al. (Berend Isermann, Triantafyllos Chavakis): Lipoprotein(a) in atherosclerotic plaques recruits inflammatory cells through interaction with Mac-1 integrin: FASEB J. 2006; 20(3):559-61
-
Berend Isermann et al. (Triantafyllos Chavakis): Activated Protein C protects against diabetic nephropathy by inhibiting endothelial and podocyte apoptosis: Nature Medicine: in press
Förderthematik der Ausschreibung des Jahres 2002:
- Carolin Schmittwolf et al. (Albrecht M Müller): In vivo haematopoietic activity is induced in neuroshere cells by chromatin-modifying agents: The EMBO Journal (2005) 24, 554-566
- Dürr, M.; Harder, F.; Müller, A.M. (2006): Developmental potential of somatic stem cells following injection into murine blastocysts. In: Ho, Hoffman, Zanjani (Eds.) Stem Cell Transplantation: WILEY-VCH
- Klinz FJ et al. (Bloch W): Phospho-eNOS Ser-114 in human mesenchymal stem cells: constitutive phosphorylation, nuclear localization and upregulation during mitosis: Eur J Cell Biol (2005) 84:809-18
- Arnhold S et al. (Bloch W): Human bone marrow stroma cells display certain neural characteristics and integrate in the subventricular compartment after injection into the liquor system: Eur J Cell Biol 2006 Jun;85(6):551-65. Epub 2006 May 2
- Brixius K et al. (Bloch W): Endothelial progenitor cells: a new target for the prevention of cardiovascular disease: Eur J Cardiovasc Prev Rehabil. 2006 Oct;13(5):705-10. Review.
- Schmidt A et al. (Schwinger R, Mehlhorn U, Bloch W): Mesenchymal stem cells transmigrate over the endothelial barrier: European Journal of Cell Biology 85 (2006) 1179-1188
- Schmidt A et al. (Mehlhorn U, Schwinger R, Bloch W): Basic Fibroblast Growth Factor Controls Migration in Human Mesenchymal Stem Cells: Stem Cells 2006; 24;1750-1758
- Ladage D et al. (Bloch W): Mesenchymal stem cells induce endothelial activation via paracine mechanisms: Endothelium. 2007 Mar-Apr;14(2):53-63.
- Schmidt A et al. (Bloch W): Endothelial Precursor Cell Migration During Vasculogenesis: Circ. Res. 2007; 101;125-136
- Funcke F et al. (Bloch W): Characterisation of the interaction between circulating and in vitro cultivated endothelial progenitor cells and the endothelial barrier: European Journal of Cell Biology: in press
- Rotter N et al. (Lang S): Isolation and Characterization of Adult Stem Cells from Human Salivary Glands: Stem Cells and Development: in press
Förderthematik der Ausschreibung des Jahres 2001:
“Molekulares Targeting zur Tumorzell- spezifischen Therapie“
-
A. Kröger et al. (H. Hauser): Activities of IRF 1. :J Interferon Cytokine Res. 22:5-14 (2002)
-
A. Kröger et al. (H. Hauser): IRF-1 reverts the transformed phenotype of oncogenically transformed cells in vitro and in vivo: Oncogene (2003) 22, 1045-1056
-
A. Wichert et al. (P. S. Holm): Glypican-3 is involved in cellular protection against mitoxantrone in gastric carcinoma cells: Oncogene (2004) 23, 945-955
-
P. S. Holm et al. (B. Gänsbacher): Multidrug-resistant Cancer Cells Facilitate E1-independent Adenoviral Replication: Impact for Cancer Gene Therapy: Cancer Research 64, 322-328, January 1, 2004
„Hämostaseologie / Antithrombotische Strategien“
- Chavakis T et al. (Preissner KT): Hämostatic factors occupy new territory: the role of the urokinase receptor system and kininogen in inflammation: Biochem Soc Trans. 2002; 30: 168-173
- Chavakis T et al. (Preissner KT): Inhibition of platelet adhesion and aggregation by a defined region (Gly-486-Lys-502) of high molecular weight kininogen: J Biol Chem: 2002; 277: 23157-23164
- Chavakis T et al. (Preissner KT): A novel antithrombotic role for high molecular weight kininogen as inhibitor of plasminogen activator inhibitor-1 function: J Biol Chem. 2002; 277:32677-32682
- Al-Fakhri N et. al. (Chavakis T, Preissner KT): Induction of apoptosis in vascular cells by plasminogen activator inhibitor-1 and high molecular weight kininogen correlates with their anti-adhesive properties: Biol Chem. 2003; 384:423-435
- Chavakis T et al. (Preissner KT): High molecular weight kininogen regulates platelet-leukocyte interactions by bridging Mac-1 and glycoprotein 1b: J Biol Chem. 2003; 278: 45375- 45381
- Chavakis T, Preissner KT: Potential pharmacological applications of the antithrombotic molecule high molecular weight kininogen: Curr Vasc Pharmacol. 2003;1: 59-64
- Kanse SM et al. (Chavakis T, Preissner KT): Variability in the expression of urokinase receptor (CD 87) mutants on cells: relevance to sell adhesion: Cell. Biochem. Funct. 2004; 22:257-264
- Wetzel A et al. (Chavakis T, Preissner KT): Human Thy-1 (CD90) on activated endothelial cells is a counterreceptor for the leukocyte integrin Mac-1 (CD11b/CD18): J. Immunol. 2004; 172:3850-3859
- Chavakis T et al. (Preissner KT): The junctional adhesion molecule-C promotes neutrophil transendothelial migration in vitro and in vivo: J. Biol. Chem. 2004; 279: 55602-55608
- Chavakis T et al. (Preissner KT): Regulation of neovascularization by human neutrophil peptides (a-defensins): a link between inflammation an angiogenesis: FASEB J. 2004; 18: 1306-1308
- Economopoulou M et al. (Chavakis T, Preissner KT): Inhibition of pathologic retinal neovascularization by alpha-defensins: Blood 2005; 106: 3831-3838
Förderthematik der Ausschreibung des Jahres 2000:
„Molekulares Targeting zur Tumorzell-spezifischen Therapie“
- Nagel-Wolfrum K et al. (Groner B):The Interaction of Specific Peptide Aptamers With the DNA Binding Domain and the Dimerization Domain of the Transcription Factor Stat3 Inhibits Transactivation and Induces Apoptosis in Tumor Cells: Molecular Cancer Research 2, 170-182, 2004
- Gottstein C et al.: Vascular targeting using STIAs (specific thrombosis inducing agents) for the treatment of Hodgkin's lymphoma: Leukemia & Lymphoma 42/2: 90, 2001
- Philipp J et al. (Gottstein C): Induction of selective tumor vessel thrombosis in a mouse model for Hodgkin's lymphoma: Onkologie 24/6: 82, 2001
- Philipp J et al. (Engert A, Gottstein C): Soluble tissue factor induces coagulation on tumor endothelial cells in vivo if coadministered with low-dose lipopolysaccharides: Art Thromb Vasc Biol 23: 905-10, 2003
- Rubio I, et al.: Quantification of absolute Ras-GDP/GTP levels by HPLC separation of Ras-bound (32P)-labelled nucleotides: . J. Biochem. Biophys. Methods 58:111-117 (2004)
- R. Pusch, I. Rubio: Echtzeit-Visualisierung kleiner GTPasen in lebenden Zellen: Laborwelt 6, 4-10 (2005)
M. Augsten et.al. (Friedrich K, Rubio I): Live-cell imaging of endogenous Ras-GTP illustrates predominant Ras activation at the plasma membrane: EMBO Rep. 7:46-51 (2006)
Förderthematik der Ausschreibung des Jahres 1999:
„Beeinflussung von Signaltransduktion und Apoptose als molekulare Strategien in der Hämato-Onkologie
-
Siegmund B et al. (Meinhard G, Emmerich B, Endres S): Phosphodiesterase type 4 inhibitor suppresses expression of anti-apoptotic members of the Bcl-2 family in B-CLL cells and induces caspase-dependent apoptosis: Leukemia (2001) 15, 1564-1571
-
Warmuth M et al. (Hallek M): Dual-specific Src and Abl kinase inhibitors, PP1 and CGP76030, inhibit growth and survival of cells expressing imatinib mesylate-resistant Bcr-Abl kinases: Blood (2003) 101 (2), 664-672
NIBR
Die Novartis Institutes for BioMedical Research (NIBR) bilden das globale Forschungsnetzwerk von Novartis.
Soziale Verantwortung
Soziale Verantwortung bei Novartis
Ein Überblick unserer Aktivitäten im Jahr 2006
PDF Download
(849 KB)